{"id":"https://openalex.org/W2108560536","doi":"https://doi.org/10.1081/dmr-120005659","title":"BIOREDUCTIVELY ACTIVATED ANTITUMORN-OXIDES: THE CASE OF AQ4N, A UNIQUE APPROACH TO HYPOXIA-ACTIVATED CANCER CHEMOTHERAPY","display_name":"BIOREDUCTIVELY ACTIVATED ANTITUMORN-OXIDES: THE CASE OF AQ4N, A UNIQUE APPROACH TO HYPOXIA-ACTIVATED CANCER CHEMOTHERAPY","alternate_titles":[],"publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2108560536","doi":"https://doi.org/10.1081/dmr-120005659","mag":"2108560536","pmid":"https://pubmed.ncbi.nlm.nih.gov/12214668"},"language":"en","primary_location":{"id":"doi:10.1081/dmr-120005659","doi":"https://doi.org/10.1081/dmr-120005659","is_oa":false,"landing_page_url":"https://doi.org/10.1081/dmr-120005659","pdf_url":null,"source":{"id":"https://openalex.org/S133743172","display_name":"Drug Metabolism Reviews","issn_l":"0360-2532","issn":["0360-2532","1097-9883"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism Reviews","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2108560536"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109260161","display_name":"Laurence H. Patterson","orcid":"https://orcid.org/0000-0002-8656-2383","observed_orcids":["https://orcid.org/0000-0002-8656-2383"]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]},{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Laurence H. Patterson","raw_affiliation_strings":["Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University of London, UK. laurence.patterson@ulsop.ac.uk","Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University of London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University of London, UK. laurence.patterson@ulsop.ac.uk","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]},{"raw_affiliation_string":"Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University of London, UK","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109260161"],"corresponding_institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"],"apc_list":null,"apc_paid":null,"fwci":0.6709,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.44776119,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"34","issue":"3","first_page":"581","last_page":"592"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.6898999810218811,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.6898999810218811,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.296099990606308,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aq4n","display_name":"AQ4N","score":1.0},{"id":"https://openalex.org/keywords/n-oxides","display_name":"N-oxides","score":0.7099999785423279},{"id":"https://openalex.org/keywords/bioreductive-activation","display_name":"bioreductive activation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/hypoxia-activated-prodrug","display_name":"hypoxia-activated prodrug","score":0.8069999814033508},{"id":"https://openalex.org/keywords/anticancer-prodrugs","display_name":"anticancer prodrugs","score":0.8339999914169312},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibition","display_name":"topoisomerase II inhibition","score":0.8379999995231628},{"id":"https://openalex.org/keywords/dna-alkylation","display_name":"DNA alkylation","score":0.6029999852180481},{"id":"https://openalex.org/keywords/cytochrome-p450-metabolism","display_name":"cytochrome P450 metabolism","score":0.8330000042915344},{"id":"https://openalex.org/keywords/cyp3a","display_name":"CYP3A","score":0.9610000252723694},{"id":"https://openalex.org/keywords/cyp1a","display_name":"CYP1A","score":0.8820000290870667},{"id":"https://openalex.org/keywords/cyp1b1","display_name":"CYP1B1","score":0.9700000286102295},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.5460000038146973},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.6520000100135803},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6940000057220459}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.9026809930801392},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.6484174132347107},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5625308752059937},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5610802173614502},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.5528792142868042},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5409970283508301},{"id":"https://openalex.org/C3018358672","wikidata":"https://www.wikidata.org/wiki/Q167198","display_name":"Tertiary amine","level":2,"score":0.47831037640571594},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4766874313354492},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45155394077301025},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4321382939815521},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.416896790266037},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3648661971092224},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.35507094860076904},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.328465074300766},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C188027245","wikidata":"https://www.wikidata.org/wiki/Q750446","display_name":"Polymer chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000880","descriptor_name":"Anthraquinones","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000880","descriptor_name":"Anthraquinones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000880","descriptor_name":"Anthraquinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007364","descriptor_name":"Intercalating Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008861","descriptor_name":"Microsomes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009589","descriptor_name":"Nitrogen Oxides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010084","descriptor_name":"Oxidation-Reduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015687","descriptor_name":"Cell Hypoxia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1081/dmr-120005659","doi":"https://doi.org/10.1081/dmr-120005659","is_oa":false,"landing_page_url":"https://doi.org/10.1081/dmr-120005659","pdf_url":null,"source":{"id":"https://openalex.org/S133743172","display_name":"Drug Metabolism Reviews","issn_l":"0360-2532","issn":["0360-2532","1097-9883"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism Reviews","raw_type":"journal-article"},{"id":"pmid:12214668","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12214668","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W25226828","https://openalex.org/W67608889","https://openalex.org/W174805935","https://openalex.org/W1259399738","https://openalex.org/W1499177907","https://openalex.org/W1529049840","https://openalex.org/W1836736439","https://openalex.org/W1964271051","https://openalex.org/W1965821019","https://openalex.org/W1966708809","https://openalex.org/W1967611636","https://openalex.org/W1968925886","https://openalex.org/W1972957002","https://openalex.org/W1982374730","https://openalex.org/W1989177534","https://openalex.org/W2004329137","https://openalex.org/W2006973371","https://openalex.org/W2018454488","https://openalex.org/W2020638356","https://openalex.org/W2021555497","https://openalex.org/W2028999918","https://openalex.org/W2046588938","https://openalex.org/W2050478879","https://openalex.org/W2052907052","https://openalex.org/W2067305000","https://openalex.org/W2068422015","https://openalex.org/W2070670105","https://openalex.org/W2072433357","https://openalex.org/W2072695465","https://openalex.org/W2084723672","https://openalex.org/W2099048452","https://openalex.org/W2104764408","https://openalex.org/W2133270655","https://openalex.org/W2149584883","https://openalex.org/W2157259121","https://openalex.org/W2180899442","https://openalex.org/W2272361922","https://openalex.org/W2284495283","https://openalex.org/W2294253330","https://openalex.org/W2300809561","https://openalex.org/W2321620835","https://openalex.org/W2395290749","https://openalex.org/W2423533587","https://openalex.org/W2473805460","https://openalex.org/W2587900863","https://openalex.org/W4246857602","https://openalex.org/W4406986034"],"related_works":["https://openalex.org/W370496702","https://openalex.org/W1979040428","https://openalex.org/W1989177534","https://openalex.org/W2006973371","https://openalex.org/W2054785151","https://openalex.org/W1499177907","https://openalex.org/W25226828","https://openalex.org/W2163801438","https://openalex.org/W2149584883","https://openalex.org/W2052907052"],"abstract_inverted_index":{"Aliphatic":[0],"amine":[1],"N-oxides":[2,21],"have":[3,112],"long":[4],"been":[5,31],"identified":[6],"as":[7],"non-toxic":[8],"metabolites":[9],"of":[10,14,19,51,67,79,92,132,153,188],"a":[11,36,59,76,82,145],"large":[12],"number":[13],"tertiary":[15],"amines":[16],"drugs.":[17],"Bioreduction":[18],"such":[20],"will":[22],"generate":[23,58],"the":[24,129,186],"active":[25],"parent":[26],"amine.":[27],"This":[28],"principle":[29],"has":[30,69,94,117],"adopted":[32],"to":[33,57,87,101,182,194,200],"develop":[34],"AQ4N,":[35],"di-N-oxide":[37],"anticancer":[38,105],"prodrug":[39,106],"with":[40],"little":[41,118],"intrinsic":[42,121],"cytotoxicity.":[43],"However,":[44],"AQ4N":[45,68,93,116,154,183,191,204],"is":[46,75,139,144,192,205],"bioreduced":[47],"in":[48,99,110,156,185,207],"hypoxic":[49],"regions":[50],"solid":[52],"tumors":[53,198],"and":[54,74,134,142,158,168,177],"micrometastatic":[55],"deposits":[56],"cytotoxic":[60,122],"alkylaminoanthraquinone":[61],"metabolite.":[62],"The":[63,90],"4-electron":[64],"reduction":[65],"metabolite":[66],"high":[70],"affinity":[71],"for":[72,147],"DNA":[73,83],"potent":[77],"inhibitor":[78],"topoisomerase":[80],"II,":[81],"processing":[84],"enzyme":[85],"crucial":[86],"cell":[88,171],"division.":[89],"development":[91],"proceeded":[95],"on":[96],"many":[97],"fronts":[98],"order":[100],"establish":[102],"this":[103],"unique":[104],"opportunity.":[107],"Preclinical":[108],"studies":[109],"vivo":[111,160],"demonstrated":[113],"that":[114,174],"although":[115],"or":[119],"no":[120],"activity":[123],"per":[124],"se":[125],"it":[126],"(i)":[127],"enhances":[128],"antitumor":[130],"effects":[131],"radiation":[133],"conventional":[135],"chemotherapeutic":[136],"agents,":[137],"(ii)":[138],"pharmacokinetically":[140],"stable,":[141],"(iii)":[143],"substrate":[146],"cytochrome":[148],"P450":[149],"(CYP).":[150],"A":[151],"study":[152],"metabolism":[155],"vitro":[157],"ex":[159],"using":[161],"purified":[162],"CYP":[163,169,202],"enzymes,":[164],"phenotyped":[165],"human":[166],"livers":[167],"transfected":[170],"lines":[172],"shows":[173],"CYP3A,":[175],"1A":[176],"1B1":[178],"family":[179],"members":[180],"contribute":[181],"bioreduction":[184],"absence":[187],"oxygen.":[189],"Importantly":[190],"shown":[193],"be":[195],"metabolized":[196],"by":[197],"known":[199],"express":[201],"isoforms.":[203],"currently":[206],"Phase":[208],"I":[209],"clinical":[210],"trials.":[211]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2108560536","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
